StockData
Cytokinetics Inc logo

Cytokinetics Inc (CYTK) stock

CYTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30
$51.65−1.52 (-2.86%)

Close on Nov 17, 2026Market cap $7.18BP/E –Yield –

Cytokinetics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Cytokinetics's operating cash flow for the twelve months ending Jun 30, 2026 was -$555.45M. For fiscal 2025 it was -$510.01M. The highest annual figure on record is $36.98M in fiscal 2016.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$510.01M–
FY2024Dec 31, 2024-$395.89M–
FY2023Dec 31, 2023-$414.33M–
FY2022Dec 31, 2022-$299.52M–
FY2021Dec 31, 2021-$142.52M-1693.7%
FY2020Dec 31, 2020$8.94M–
FY2019Dec 31, 2019-$90.91M–
FY2018Dec 31, 2018-$101.22M–
FY2017Dec 31, 2017-$101.76M-375.2%
FY2016Dec 31, 2016$36.98M+657.4%
FY2015Dec 31, 2015$4.88M–
FY2014Dec 31, 2014-$44.84M–
FY2013Dec 31, 2013-$7.72M–
FY2012Dec 31, 2012-$33.44M–
FY2011Dec 31, 2011-$45.60M–
FY2010Dec 31, 2010-$44.83M-632.7%
FY2009Dec 31, 2009$8.42M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$159.84M–
Q1 FY2026Mar 31, 2026-$145.46M–
Q4 FY2025Dec 31, 2025-$142.65M–
Q3 FY2025Sep 30, 2025-$107.51M–
Q2 FY2025Jun 30, 2025-$128.24M–
Q1 FY2025Mar 31, 2025-$131.62M–
Q4 FY2024Dec 31, 2024-$65.57M–
Q3 FY2024Sep 30, 2024-$101.50M–
Q2 FY2024Jun 30, 2024-$99.31M–
Q1 FY2024Mar 31, 2024-$129.51M–
Q4 FY2023Dec 31, 2023-$74.04M–
Q3 FY2023Sep 30, 2023-$96.21M–
Q2 FY2023Jun 30, 2023-$121.81M–
Q1 FY2023Mar 31, 2023-$122.29M–
Q4 FY2022Dec 31, 2022-$98.19M–
Q3 FY2022Sep 30, 2022-$84.04M–
Q2 FY2022Jun 30, 2022-$90.48M–
Q1 FY2022Mar 31, 2022-$26.81M–
Q4 FY2021Dec 31, 2021-$44.74M-185.8%
Q3 FY2021Sep 30, 2021-$38.77M-369.9%
Q2 FY2021Jun 30, 2021-$29.50M–
Q1 FY2021Mar 31, 2021-$29.52M–
Q4 FY2020Dec 31, 2020$52.15M–
Q3 FY2020Sep 30, 2020$14.37M–
Q2 FY2020Jun 30, 2020-$27.44M–
Q1 FY2020Mar 31, 2020-$30.14M–
Q4 FY2019Dec 31, 2019-$19.06M–
Q3 FY2019Sep 30, 2019-$20.27M–
Q2 FY2019Jun 30, 2019-$24.68M–
Q1 FY2019Mar 31, 2019-$26.91M–
Q4 FY2018Dec 31, 2018-$12.33M–
Q3 FY2018Sep 30, 2018-$32.24M–
Q2 FY2018Jun 30, 2018-$26.85M–
Q1 FY2018Mar 31, 2018-$29.81M–
Q4 FY2017Dec 31, 2017-$24.07M-130.9%
Q3 FY2017Sep 30, 2017-$25.48M–
Q2 FY2017Jun 30, 2017-$31.26M–
Q1 FY2017Mar 31, 2017-$20.94M–
Q4 FY2016Dec 31, 2016$77.83M–
Q3 FY2016Sep 30, 2016-$12.12M–

More Cytokinetics figures

See a number that looks wrong?